Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lupin patents CaSR modulators

March 4, 2015

Alize Pharma begins phase II trial of AZP-531 in Prader-Willi syndrome

March 4, 2015

Dilafor releases results from safety and pharmacokinetic study of tafoxiparin

March 4, 2015

FDA approves Liletta to prevent pregnancy for up to three years

March 4, 2015

FDA accepts Alexion's BLA for asfotase alfa in hypophosphatasia for priority review

March 3, 2015

German organization patents GRK5 modulators

March 2, 2015

Amarin and Eddingpharm sign Vascepa agreement for China

March 2, 2015

Amgen reports results from phase III trial comparing AMG-416 and cinacalcet in SHPT

Feb. 27, 2015

Takeda describes FFA1 receptor agonists for diabetes

Feb. 26, 2015

CymaBay reports phase IIb results for arhalofenate in gout

Feb. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...